PMID- 16461778 OWN - NLM STAT- MEDLINE DCOM- 20060725 LR - 20210217 IS - 0022-2275 (Print) IS - 0022-2275 (Linking) VI - 47 IP - 5 DP - 2006 May TI - Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase. PG - 1054-62 AB - Oxidized phospholipids stimulate endothelial cells to bind monocytes, but not neutrophils, an initiating event in atherogenesis. Here, we investigate intracellular signaling events induced by oxidized phospholipids in human umbilical vein endothelial cells (HUVECs) that lead to specific monocyte adhesion. In a static adhesion assay, oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine and one of its components, 1-palmitoyl-2-oxovaleroyl-sn-glycero-3-phosphorylcholine, stimulated HUVECs to bind U937 cells and human peripheral blood monocytes but not HL-60 cells or blood neutrophils. Monocyte adhesion was dependent on protein kinases A and C, extracellular signal-regulated kinase 1/2, p38 mitogen activated protein kinases (MAPKs), and cytosolic phospholipase A(2) (cPLA(2)). Inhibition of 12-lipoxygenase (12-LOX), but not cyclooxygenases, blocked monocyte adhesion, and addition of 12-hydroxyeicosatetraenoic acid (12-HETE) mimicked the effects of oxidized phospholipids. Peroxisome proliferator-activated receptor alpha (PPARalpha) was excluded as a possible target for 12-HETE, because monocyte adhesion was still induced in endothelial cells from PPARalpha null mice. Together, our results suggest that oxidized phospholipids stimulate HUVECs to specifically bind monocytes involving MAPK pathways, which lead to the activation of cPLA(2) and 12-LOX. Further analysis of signaling pathways induced by oxidized phospholipids that lead to specific monocyte adhesion should ultimately lead to the development of novel therapeutic approaches against chronic inflammatory diseases. FAU - Huber, Joakim AU - Huber J AD - Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, Austria. FAU - Furnkranz, Alexander AU - Furnkranz A FAU - Bochkov, Valery N AU - Bochkov VN FAU - Patricia, Mary K AU - Patricia MK FAU - Lee, Hans AU - Lee H FAU - Hedrick, Catherine C AU - Hedrick CC FAU - Berliner, Judith A AU - Berliner JA FAU - Binder, Bernd R AU - Binder BR FAU - Leitinger, Norbert AU - Leitinger N LA - eng GR - HL-30568/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20060205 PL - United States TA - J Lipid Res JT - Journal of lipid research JID - 0376606 RN - 0 (1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine) RN - 0 (Phosphatidylcholines) RN - 0 (Phospholipid Ethers) RN - 0 (oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine) RN - 27YG812J1I (Arachidonic Acid) RN - EC 1.13.11.12 (Lipoxygenase) RN - EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthases) RN - EC 2.7.11.13 (Protein Kinase C) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - EC 3.1.1.32 (Phospholipases A) SB - IM MH - Animals MH - Arachidonic Acid/physiology MH - Cell Adhesion/drug effects/*physiology MH - Cells, Cultured MH - Cytosol/enzymology MH - Endothelium, Vascular/*cytology MH - Enzyme Activation MH - Humans MH - Lipoxygenase/*metabolism MH - MAP Kinase Signaling System/physiology MH - Mice MH - Monocytes/*physiology MH - Phosphatidylcholines/*pharmacology MH - Phospholipases A/*metabolism MH - Phospholipid Ethers/pharmacology MH - Prostaglandin-Endoperoxide Synthases/physiology MH - Protein Kinase C/physiology MH - Signal Transduction MH - p38 Mitogen-Activated Protein Kinases/physiology EDAT- 2006/02/08 09:00 MHDA- 2006/07/26 09:00 CRDT- 2006/02/08 09:00 PHST- 2006/02/08 09:00 [pubmed] PHST- 2006/07/26 09:00 [medline] PHST- 2006/02/08 09:00 [entrez] AID - S0022-2275(20)33254-5 [pii] AID - 10.1194/jlr.M500555-JLR200 [doi] PST - ppublish SO - J Lipid Res. 2006 May;47(5):1054-62. doi: 10.1194/jlr.M500555-JLR200. Epub 2006 Feb 5.